Inspire Medical Systems released preliminary results indicated second-quarter and full-year revenue above analysts' estimates. The sleep apnea device maker expects second quarter sales to be 30% ...

ResMed's Chief Medical Officer has suggested doctors will prescribe using both drugs and devices such as his company makes together to help sleep apnea suffers. Shares of ResMed (RMD) and Inspire ...

The company develops minimally invasive solutions for patients with obstructive sleep apnea (OSA ... wouldn’t be good candidates for Inspire’s device, which is designed to prevent airway ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea ... ResMed (RMD) and Inspire Medical Systems (INSP). - Inspire has developed a neurostimulation device approved by the ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...